Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: A long term follow-up analysis

Journal of Surgical Oncology

Volumn 88, Issue 1, 2004, Pages 4-7

  Torrenga, Hans ^a   Fabry, Hans ^a   Van Der Sijp, Joost R M ^a   Van Diest, Paul J ^a   Pijpers, Rik ^a   Meijer, Sybren ^a   Nieweg, Omgo E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast neoplasm; Follow up study; Recurrence; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BONE METASTASIS; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

EID: 4744373148     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20101     Document Type: Article

References (14)

1. Nieweg OE, Jansen L, Valdés Olmos RA, et al.: Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999;26:S11-S16.
2. Nieweg OE, Tanis PJ, De Vries JDH, et al.: Sensitivity of sentinel node biopsy in melanoma. J Surg Oncol 2001;78:223-224.
3. Fredriksson I, Liljegren G, Arnesson LG, et al.: Consequences of axillary recurrence after conservative breast surgery. Br J Surg 2002;89:902-908.
4. Recht A, Pierce SM, Abner A, et al.: Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988-996.
5. Giuliano AE, Haigh PI, Brennan MB, et al.: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-2559.
6. Roumen RM, Kuijt GP, Liem IH, et al.: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001;88:1639-1643.
7. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, et al.: Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77:165-170.
8. Guenther JM: Dye-directed sentinel node biopsy for breast cancer. Ann Surg Oncol 2002;9:S56.
9. Bedrosian I, Heimbach B, Spitz F, et al.: A prospective study of sentinel lymph node biopsy without axillary node dissection for staging patients with breast cancer. Ann Surg Oncol 2002;9: S57-S58.
10. Chung MA, Steinhoff MM, Cady B: Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310-314.
11. Nieweg OE, Estourgie SH: Summary of the Third International Sentinel Node Conference 16-18 November 2002, Yokohama. Eur J Nucl Med Mol Imaging 2003;30:483-487.
12. Badgwell BD, Povoski SP, Abdessalam SF, et al.: Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 2003;10:376-380.
13. Reitsamer R, Peintinger F, Prokop E, et al.: Sentinel lymph node biopsy alone without axillary lymph node dissection-follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2003;29:221-223.
14. Torrenga H, Fabry H, Van der Sijp JRM, et al.: Omitting axillary lymph node dissection in sentinel node negative breast cancer patients in safe: A long-term follow-up analysis. J Surg Oncol 2004;88:4-8.